Open Access

Gut Microbes

, том 15 , издание 1

Advancing therapeutics for recurrent clostridioides difficile infections: an overview of vowst’s FDA approval and implications

Nityanand Jain ^{1, 2}

Neslihan Üstündağ Okur ³

Anne Fleur Fahner ^{4, 5}

Valdis Ģībietis ⁶

Скрыть аффилиации авторов Показать аффилиации авторов: 6 аффилиаций

Faculty of Medicine, Riga Stradinš University, Riga, Latvia |

Joint Microbiology Laboratory, Pauls Stradinš Clinical University Hospital, Riga, Latvia |

Faculty of Medicine, Sriwijaya University, Palembang, Indonesia |

⁴

Department of Immunology and infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA |

⁵

Faculty of Biomedical Sciences, Vrije Universiteit, Amsterdam, Netherlands |

⁶

Department of Internal Diseases, Riga Stradinš University, Riga, Latvia |

Тип публикации: Journal Article

Дата публикации: 2023-07-11

Taylor & Francis

Gut Microbes

scimago Q1

wos Q1

БС1

SJR: 3.609

CiteScore: 18.2

Impact factor: 11.0

ISSN: 19490976, 19490984

DOI: 10.1080/19490976.2023.2232137

Скопировать DOI

PubMed ID: 37431860

Microbiology (medical)

Microbiology

Infectious Diseases

Gastroenterology

Найдено

3 цитирования

Вернись Эгги

27 публикаций, 1 222 цитирования, 20 рецензий

Индекс Хирша: 12

2 цитирования

Дюпон Герберт

603 публикации, 29 512 цитирований, 1 рецензия

Индекс Хирша: 90

Медицинский колледж Бэйлора

Центр медицинских наук Техасского университета в Хьюстоне

1 цитирование

Клу Десмонд

🥼 🤝

PhD, ст. преп.

38 публикаций, 2 457 цитирований, 2 рецензии

Индекс Хирша: 10

Университет здравоохранения и смежных наук

Топ-30

Журналы

	1 2
Frontiers in Microbiology	Frontiers in Microbiology, 2, 3.85% Frontiers in Microbiology 2 публикации, 3.85%
Frontiers in Immunology	Frontiers in Immunology, 2, 3.85% Frontiers in Immunology 2 публикации, 3.85%
Pathogens	Pathogens, 2, 3.85% Pathogens 2 публикации, 3.85%
Journal of Clinical Medicine	Journal of Clinical Medicine, 2, 3.85% Journal of Clinical Medicine 2 публикации, 3.85%
Journal of Hospital Infection	Journal of Hospital Infection, 2, 3.85% Journal of Hospital Infection 2 публикации, 3.85%
Advanced Drug Delivery Reviews	Advanced Drug Delivery Reviews, 2, 3.85% Advanced Drug Delivery Reviews 2 публикации, 3.85%
Nature Communications	Nature Communications, 2, 3.85% Nature Communications 2 публикации, 3.85%
Microbiology Research	Microbiology Research, 1, 1.92% Microbiology Research 1 публикация, 1.92%
Antibiotics	Antibiotics, 1, 1.92% Antibiotics 1 публикация, 1.92%
Infection and Drug Resistance	Infection and Drug Resistance, 1, 1.92% Infection and Drug Resistance 1 публикация, 1.92%
European Journal of Medical Research	European Journal of Medical Research, 1, 1.92% European Journal of Medical Research 1 публикация, 1.92%
British Journal of Pharmacology	British Journal of Pharmacology, 1, 1.92% British Journal of Pharmacology 1 публикация, 1.92%
Alimentary Pharmacology and Therapeutics	Alimentary Pharmacology and Therapeutics, 1, 1.92% Alimentary Pharmacology and Therapeutics 1 публикация, 1.92%
Science in One Health	Science in One Health, 1, 1.92% Science in One Health 1 публикация, 1.92%
AAPS PharmSciTech	AAPS PharmSciTech, 1, 1.92% AAPS PharmSciTech 1 публикация, 1.92%
Gut	Gut, 1, 1.92% Gut 1 публикация, 1.92%
ACS Infectious Diseases	ACS Infectious Diseases, 1, 1.92% ACS Infectious Diseases 1 публикация, 1.92%
Journal of Molecular Structure	Journal of Molecular Structure, 1, 1.92% Journal of Molecular Structure 1 публикация, 1.92%
Immunity	Immunity, 1, 1.92% Immunity 1 публикация, 1.92%
Heliyon	Heliyon, 1, 1.92% Heliyon 1 публикация, 1.92%
Future Microbiology	Future Microbiology, 1, 1.92% Future Microbiology 1 публикация, 1.92%
Gut Microbes	Gut Microbes, 1, 1.92% Gut Microbes 1 публикация, 1.92%
Therapeutic Advances in Gastroenterology	Therapeutic Advances in Gastroenterology, 1, 1.92% Therapeutic Advances in Gastroenterology 1 публикация, 1.92%
Colloids and Surfaces B: Biointerfaces	Colloids and Surfaces B: Biointerfaces, 1, 1.92% Colloids and Surfaces B: Biointerfaces 1 публикация, 1.92%
Ageing Research Reviews	Ageing Research Reviews, 1, 1.92% Ageing Research Reviews 1 публикация, 1.92%
Cells	Cells, 1, 1.92% Cells 1 публикация, 1.92%
Experimental Dermatology	Experimental Dermatology, 1, 1.92% Experimental Dermatology 1 публикация, 1.92%
The Lancet Infectious Diseases	The Lancet Infectious Diseases, 1, 1.92% The Lancet Infectious Diseases 1 публикация, 1.92%
Drugs and Drug Candidates	Drugs and Drug Candidates, 1, 1.92% Drugs and Drug Candidates 1 публикация, 1.92%
	1 2

Издатели

	2 4 6 8 10 12 14 16
Elsevier	Elsevier, 15, 28.85% Elsevier 15 публикаций, 28.85%
MDPI	MDPI, 9, 17.31% MDPI 9 публикаций, 17.31%
Springer Nature	Springer Nature, 7, 13.46% Springer Nature 7 публикаций, 13.46%
Frontiers Media S.A.	Frontiers Media S.A., 5, 9.62% Frontiers Media S.A. 5 публикаций, 9.62%
Wiley	Wiley, 5, 9.62% Wiley 5 публикаций, 9.62%
Taylor & Francis	Taylor & Francis, 3, 5.77% Taylor & Francis 3 публикации, 5.77%
American Chemical Society (ACS)	American Chemical Society (ACS), 2, 3.85% American Chemical Society (ACS) 2 публикации, 3.85%
BMJ	BMJ, 1, 1.92% BMJ 1 публикация, 1.92%
SAGE	SAGE, 1, 1.92% SAGE 1 публикация, 1.92%
The Japan Society of Coloproctology	The Japan Society of Coloproctology, 1, 1.92% The Japan Society of Coloproctology 1 публикация, 1.92%
American Society for Microbiology	American Society for Microbiology, 1, 1.92% American Society for Microbiology 1 публикация, 1.92%
Oxford University Press	Oxford University Press, 1, 1.92% Oxford University Press 1 публикация, 1.92%
	2 4 6 8 10 12 14 16

Мы не учитываем публикации, у которых нет DOI.
Статистика публикаций обновляется еженедельно.

Вы ученый?

Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.

Войти с ORCID

PDF

Метрики

Цитировать

ГОСТ |

Цитировать

ГОСТ Скопировать

Jain N. et al. Advancing therapeutics for recurrent clostridioides difficile infections: an overview of vowst’s FDA approval and implications // Gut Microbes. 2023. Vol. 15. No. 1.

ГОСТ со всеми авторами (до 50) Скопировать

Jain N., Üstündağ Okur N., Fahner A. F., Ģībietis V. Advancing therapeutics for recurrent clostridioides difficile infections: an overview of vowst’s FDA approval and implications // Gut Microbes. 2023. Vol. 15. No. 1.

RIS |

Цитировать

RIS Скопировать

TY - JOUR

DO - 10.1080/19490976.2023.2232137

UR - https://doi.org/10.1080/19490976.2023.2232137

TI - Advancing therapeutics for recurrent clostridioides difficile infections: an overview of vowst’s FDA approval and implications

T2 - Gut Microbes

AU - Jain, Nityanand

AU - Üstündağ Okur, Neslihan

AU - Fahner, Anne Fleur

AU - Ģībietis, Valdis

PY - 2023

DA - 2023/07/11

PB - Taylor & Francis

IS - 1

VL - 15

PMID - 37431860

SN - 1949-0976

SN - 1949-0984

ER -

BibTex

Цитировать

BibTex (до 50 авторов) Скопировать

@article{2023_Jain,

author = {Nityanand Jain and Neslihan Üstündağ Okur and Anne Fleur Fahner and Valdis Ģībietis},

title = {Advancing therapeutics for recurrent clostridioides difficile infections: an overview of vowst’s FDA approval and implications},

journal = {Gut Microbes},

year = {2023},

volume = {15},

publisher = {Taylor & Francis},

month = {jul},

url = {https://doi.org/10.1080/19490976.2023.2232137},

number = {1},

doi = {10.1080/19490976.2023.2232137}

}

Издатель

Taylor & Francis

Журнал

Gut Microbes

scimago Q1

wos Q1

БС1

SJR

3.609

CiteScore

18.2

Impact factor

11.0

ISSN

19490976 (Print)

19490984 (Electronic)